Skip to content

In the BioHarmony Drug Report Database

Sevelamer

Renagel (sevelamer) is a small molecule pharmaceutical. Sevelamer was first approved as Renagel on 1998-10-30. It is used to treat hyperphosphatemia in the USA. It has been approved in Europe to treat hyperphosphatemia and renal dialysis.
Trade Name Renagel
Common Name Sevelamer
Indication hyperphosphatemia, renal dialysis
Drug Class Polymers
Sevelamer
Get full access now